Lanreotide · source year
1 selected, source-linked Lanreotide records carrying a 2023 source date. This is a navigational view of PeptideScanner’s selected coverage—not a complete research timeline or a statement about safety or effectiveness.
1 selected record.
1 represented type.
1 distinct public record.
Cited chronology
Clinical trials
PeptideScanner retained ClinicalTrials.gov record NCT03043664 at 2026-07-30T19:11:49.726Z. Its registry update date was 2023-06-29, and PeptideScanner's reviewed identity mapping was lanreotide.
Source: ClinicalTrials.gov ↗